D08667 | |
D number | D08667 |
Classification | Drug |
Name | Calcium valproate; Valproic acid calcium salt; Convulsofin (TN) |
Component | - |
Formula | (C8H15O2)2. Ca |
Exact mass | 326.177 |
Mol weight | 326.485 |
Structural formula | ![]() |
Sequence | - |
Sequence type | - |
Source | - |
Upper DGroup | Neuropsychiatric agent DG02035 Fatty acid antiepileptics Other DG01575 Calcium channel blocker DG01573 Calcium channel T type blocker Cyp substrate DG01633 CYP3A substrate |
Remark | ATC code: N03AG01 Chemical group: DG00849 |
Activity | - |
Disease | - |
Comment | Fatty acid derivative Valproic acid is contraindicated in patients with known urea cycle disorders [DS:H00164 H00185 H00186 H00187 H01028 H01032] |
Target | ABAT [HSA:18] [KO:K13524]; SSADH [HSA:7915] [KO:K00139]; GAD [HSA:2571 2572] [KO:K01580]; CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854] |
Metabolism | - |
Interaction | Genomic biomarker: (1) NAGS [HSA:162417], CPS [HSA:1373], ASS [HSA:445], OTC [HSA:5009], ASL [HSA:435], ARG [HSA:383 384], (2) POLG [HSA:5428] |
Other DBs | CAS: 33433-82-8 PubChem: 96025350 LigandBox: D08667 NIKKAJI: J308.487F |
KCF data | - |